CONTERA PHARMA
LIVE

Serial Number

79375030

Owner

Contera Pharma A/S

Attorney

Julie A. Greenberg

Filing Date

Jun 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CONTERA PHARMA Trademark

Serial Number: 79375030 • Registration: 7554196

CONTERA PHARMA is a trademark filed by Contera Pharma A/S on June 19, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Contera Pharma A/S (5 trademarks)

Venlighedsvej 4

Entity Type: 24

Contera Pharma ApS (2 trademarks)

Ole Maaløes Vej 3
Copenhagen N DK-2200 , DK

Entity Type: 16

Trademark Details

Filing Date

June 19, 2023

Registration Date

November 5, 2024

Published for Opposition

August 20, 2024

Goods & Services

Pharmaceutical sales promotion for others; business information on pharmaceuticals; business management assistance on pharmaceuticals; analysis of market search data; market research studies; advertising services; arranging of pharmaceutical sale, namely, procuring of contracts for others for the purchase and sale of pharmaceuticals; export-import agency services; sales agency business of health supplementary food, namely, marketing services for health supplementary foods, promotional marketing and representation services for sales to the public sector of health supplementary food, independent sales representatives in the field of health supplementary food; retail store services in the field of cosmetics; retail store services in the field of dentifrices; retail store services in the field of toothbrushes

Antibiotics; antivirals, chemical preparations for pharmaceutical purposes, namely, for treatment, prevention or alleviation of diseases of the central nervous system, neurological disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's Disease, dyskinesias and complications arising from same; drugs for medical purposes, namely, pharmaceutical preparations for the treatment, prevention or alleviation of diseases of the central nervous system, neurological disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's Disease, dyskinesias and complications arising from same; medicines for human purposes for treatment, prevention or alleviation of diseases of the central nervous system, neurological disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's Disease, dyskinesias and complications arising from same; pharmaceutical preparations for the treatment, prevention or alleviation of diseases of the central nervous system, neurological disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's Disease, dyskinesias and complications arising from same; vitamin preparations; health supplements for medical use, namely, health food supplements, dietary and nutritional supplements, and herbal supplements

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 6, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 6, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 6, 2026 REAP
INTERNATIONAL REGISTRATION RENEWED
Oct 2, 2025 RNWL
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 22, 2025 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 26, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 8, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 8, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 5, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 10, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 22, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 19, 2024 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 19, 2024 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 29, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 29, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 29, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 7, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 4, 2023 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 21, 2023 SDRC